DifGen Acquires FDA-Registered Finished Dosage Manufacturing Facility in Florida
18 Mar 2024 //
PR NEWSWIRE
DifGen Pharmaceuticals Successfully Launches A Second Product - Buprenorphine
02 Nov 2023 //
PR NEWSWIRE
DifGen Completes USFDA Audit of Manufacturing Site Aveva Drug Delivery Systems
06 Sep 2023 //
PR NEWSWIRE
DifGen Pharmaceuticals Acquires Aveva Drug Delivery Services Inc
24 Apr 2023 //
PR NEWSWIRE